ID: ALA4171911

Max Phase: Preclinical

Molecular Formula: C47H54N8O5

Molecular Weight: 811.00

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(N)=O

Standard InChI:  InChI=1S/C47H54N8O5/c1-29(2)22-38(43(48)56)52-46(59)41(25-32-27-50-36-20-12-10-18-34(32)36)55-45(58)40(24-31-16-8-5-9-17-31)53-47(60)42(26-33-28-51-37-21-13-11-19-35(33)37)54-44(57)39(49-3)23-30-14-6-4-7-15-30/h4-21,27-29,38-42,49-51H,22-26H2,1-3H3,(H2,48,56)(H,52,59)(H,53,60)(H,54,57)(H,55,58)/t38-,39+,40-,41+,42+/m0/s1

Standard InChI Key:  DRYABMBZFPAGHW-CTLZPSQBSA-N

Associated Targets(Human)

NCI-H69 709 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DMS-79 150 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 811.00Molecular Weight (Monoisotopic): 810.4217AlogP: 3.98#Rotatable Bonds: 20
Polar Surface Area: 203.10Molecular Species: NEUTRALHBA: 6HBD: 8
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.94CX Basic pKa: 8.34CX LogP: 4.98CX LogD: 3.99
Aromatic Rings: 6Heavy Atoms: 60QED Weighted: 0.06Np Likeness Score: 0.04

References

1. Haitham Abusara O, Freeman S, Aojula HS..  (2017)  Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain.,  137  [PMID:28595067] [10.1016/j.ejmech.2017.05.053]

Source